Sunshine Biopharma Inc Warrant
SBFMW
3 hedge funds and large institutions have $11K invested in Sunshine Biopharma Inc Warrant in 2025 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and closing their positions.
0% more funds holding
Funds holding: 3 → 3 (0)
1.55% less ownership
Funds ownership: 3.02% → 1.47% (-1.5%)
10% less capital invested
Capital invested by funds: $12.2K → $11K (-$1.2K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$2.61K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$1.33K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
UBS Group
Zurich,
Switzerland
| $5.65K | -$1.33K | -5,162 | -17% |
|
|
2
Citadel Advisors
Miami,
Florida
| $5.31K | -$2.61K | -10,130 | -33% |
|
|
CS
3
Clear Street
New York
| $27 | – | – | – |
|
SBFMW Hedge Fund Activity: Q2 2025 in Review
3 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in Sunshine Biopharma Inc Warrant (SBFMW) for Q2 2025, worth a combined $11K — down 9.8% from $12.2K a quarter earlier.
Fund positioning in SBFMW was balanced in Q2 2025: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 2 trimmed.
The largest seller was Citadel Advisors, cutting an estimated $2.61K.
- 3 institutional investors held Sunshine Biopharma Inc Warrant (SBFMW) as of Q2 2025, unchanged from Q1 2025.
- Funds reported $11K of Sunshine Biopharma Inc Warrant stock for Q2 2025, down 9.8% quarter-over-quarter.
- 0 funds opened new Sunshine Biopharma Inc Warrant positions in Q2 2025 and 0 closed out.
- The largest Sunshine Biopharma Inc Warrant seller in Q2 2025 was Citadel Advisors, an estimated $2.61K sold.
Based on aggregated 13F filings for Q2 2025.